VAXXINITY INC - COMMON STK (VAXX)

CUSIP: 92244V104

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / COMMON STK
Total 13F shares
12,566,605
Share change
+628,072
Total reported value
$10,678,739
Price per share
$0.85
Number of holders
58
Value change
+$441,984
Number of buys
28
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 92244V104?
CUSIP 92244V104 identifies VAXX - VAXXINITY INC - COMMON STK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of VAXXINITY INC - COMMON STK (VAXX) as of Q4 2023

As of 31 Dec 2023, VAXXINITY INC - COMMON STK (VAXX) was held by 58 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,566,605 shares. The largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, BANK OF AMERICA CORP /DE/, NORTHERN TRUST CORP, Creative Planning, MORGAN STANLEY, and BRIDGEWAY CAPITAL MANAGEMENT, LLC. This page lists 58 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.